ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

DCE Board Approves Recompetition Concepts

March 18, 1988

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008

NCI Clarifies P01 Grant Application Dates

September 13, 1996